Consainsights logo
Reports > Life Sciences > Allergy Diagnostics Market Report

Allergy Diagnostics Market Size, Share, Industry Trends and Forecast to 2033

This report provides a comprehensive analysis of the Allergy Diagnostics market, covering key insights, trends, technologies, and a detailed forecast from 2023 to 2033, exploring market dynamics and opportunities for growth.

Metric Value
Study Period 2023 - 2033
2023 Market Size $8.50 Billion
CAGR (2023-2033) 7.2%
2033 Market Size $17.38 Billion
Top Companies Thermo Fisher Scientific, Roche Diagnostics, Mylan N.V., Abbott Laboratories, LG Chem
Last Modified Date 15 Nov 2024

Allergy Diagnostics Market Report (2023 - 2033)

Allergy Diagnostics Market Overview

The Allergy Diagnostics industry is witnessing robust growth fueled by the increasing prevalence of allergies globally. The market is characterized by a variety of diagnostic methods including skin tests, serum-specific IgE tests, and newer molecular-based assays. The industry is also embracing technology-driven innovation, which enhances the accuracy and efficiency of tests. Moreover, the growing healthcare expenditures and the increasing focus on preventive healthcare significantly contribute to market growth. Competitors in this space are focused on mergers, acquisitions, and collaborations to enhance their product offerings and expand their market reach.

What is the Market Size & CAGR of Allergy Diagnostics market in 2023?

The Allergy Diagnostics market was valued at approximately $13.3 billion in 2023, with a projected Compound Annual Growth Rate (CAGR) of 8.2% expected from 2023 to 2033. This growth can be attributed to increased awareness of allergic conditions and the desire for effective diagnostic solutions, alongside advancements in technology that improve test accuracy and patient outcomes. The global rise in allergic diseases, influenced by various environmental and genetic factors, also plays a crucial role in supporting market expansion.

Allergy Diagnostics Industry Analysis

The Allergy Diagnostics industry is witnessing robust growth fueled by the increasing prevalence of allergies globally. The market is characterized by a variety of diagnostic methods including skin tests, serum-specific IgE tests, and newer molecular-based assays. The industry is also embracing technology-driven innovation, which enhances the accuracy and efficiency of tests. Moreover, the growing healthcare expenditures and the increasing focus on preventive healthcare significantly contribute to market growth. Competitors in this space are focused on mergers, acquisitions, and collaborations to enhance their product offerings and expand their market reach.

Allergy Diagnostics Market Segmentation and Scope

The Allergy Diagnostics market is segmented into several categories, primarily by test type, product type, allergen type, and end-user. Key segments include diagnostic kits, skin prick tests, and serological assays, which are essential for identifying specific allergies. Each segment plays a significant role in providing a thorough understanding of allergic disorders and their treatments. The market scope extends to various healthcare settings, including hospitals, diagnostic laboratories, and home care settings, highlighting the diverse applications and importance of these diagnostic methods in the healthcare landscape.

Request a custom research report for industry.

Allergy Diagnostics Market Analysis Report by Region

Europe Allergy Diagnostics Market Report:

Europe's Allergy Diagnostics market is anticipated to rise from $2.67 billion in 2023 to $5.46 billion by 2033. Factors like increased public health initiatives, a robust healthcare infrastructure, and rising allergy incidences fuel this expansion.

Asia Pacific Allergy Diagnostics Market Report:

In the Asia Pacific region, the Allergy Diagnostics market is poised to grow from $1.62 billion in 2023 to $3.32 billion by 2033. The escalating cases of inhalant allergens and food-related allergies combined with rising healthcare spending and improved diagnostic infrastructure contribute significantly to this growth.

North America Allergy Diagnostics Market Report:

North America holds a strong position in the Allergy Diagnostics market, with estimates suggesting it will grow from $2.90 billion in 2023 to $5.93 billion by 2033. The region benefits from advanced healthcare systems, high prevalence rates of allergic conditions, and significant investment in new technologies.

South America Allergy Diagnostics Market Report:

The South America Allergy Diagnostics market is expected to increase from $0.55 billion in 2023 to $1.12 billion by 2033. The growth is driven by an increasing awareness of allergic diseases and the adoption of novel diagnostic methods aided by better healthcare access.

Middle East & Africa Allergy Diagnostics Market Report:

The Middle East and Africa market is expected to grow from $0.76 billion in 2023 to $1.56 billion by 2033, aided by increasing healthcare investments and initiatives dealing with rising allergic cases driven by environmental changes.

Request a custom research report for industry.

Allergy Diagnostics Market Analysis By Product Type

Global Allergy Diagnostics Market, By Product Type Market Analysis (2023 - 2033)

In 2023, the market for various product types in Allergy Diagnostics saw significant value distribution. Diagnostic kits dominated, valued at $5.72 billion in 2023, representing a 67.34% market share, and expected to reach $11.70 billion by 2033. Serological assays and laboratory services also held considerable shares, with values emerging at $1.93 billion (22.73%) and expected to scale up to $3.95 billion respectively by 2033.

Allergy Diagnostics Market Analysis By Allergen Type

Global Allergy Diagnostics Market, By Allergen Type Market Analysis (2023 - 2033)

The allergen type segment highlights significant contributors such as pollen, food allergens, and pet dander. Pollen, which constituted 57.05% of the market share in 2023 at $4.85 billion, will double to reach $9.91 billion in 2033. Food allergens and pet dander followed suit, progressing from $1.73 billion (20.37%) and $0.88 billion (10.33%) in 2023 to $3.54 billion and $1.79 billion respectively in 2033.

Allergy Diagnostics Market Analysis By Test Type

Global Allergy Diagnostics Market, By Test Type Market Analysis (2023 - 2033)

The differentiation of tests reveals a major dominance by skin prick tests and point-of-care devices, each generating substantial revenue by 2033. Skin prick tests grossed around $5.72 billion in 2023, with an excellent retention of market share at 67.34%, projected to sustain the same share till 2033.

Allergy Diagnostics Market Analysis By End User

Global Allergy Diagnostics Market, By End-User Market Analysis (2023 - 2033)

Hospitals remained the leading end-user segment at a market size of $5.72 billion (67.34% share) in 2023 and is expected to rise to $11.70 billion by 2033, reflecting the increasing reliance on clinical environments for allergy diagnostics.

Request a custom research report for industry.

Global Market Leaders and Top Companies in Allergy Diagnostics Industry

Thermo Fisher Scientific:

A leading player in the field, known for its extensive range of allergy diagnostics and innovative testing technologies.

Roche Diagnostics:

Renowned for its diagnostic solutions, particularly in serology and molecular assays aimed at allergy testing.

Mylan N.V.:

A significant contributor in the development of allergy treatments and diagnostic kits, enhancing accessibility.

Abbott Laboratories:

Offers a broad array of allergy diagnostics and has made strides in integrating technology with diagnostic processes.

LG Chem:

Investing in research for new serological methods to improve testing accuracy in allergy diagnostics.

We're grateful to work with incredible clients.

Datasite
Agilent
Asten Johnson
Bio-Rad
Carl Zeiss
Dywidag
Illumina
LEK Consulting
Shell

Related Industries

    FAQs